Patents Assigned to Stanley Drug Products, Inc.
  • Method of treating a water soluble capsule
    Patent number: 4278633
    Abstract: A gelatin capsule is formed with an elongated portion and a bulb portion with a medicinal material therein for supply to a body through inserting the elongated portion in a body orifice. The elongated portion is treated with a hardening agent which withdraws water and/or glycerin from the elongated portion of the capsule so that the elongated portion has sufficient rigidity for insertion within the body orifice. The hardening agent can be a polymer of a glycol, which is preferably polyethylene glycol, an inorganic drying agent such as silica gel or phosphorus pentoxide, an alcohol, or a ketone, such as acetone, for example. When a polymer of a glycol is utilized as the hardening agent, the polymer of a glycol can remain on the elongated portion to function as a lubricant when the elongated portion is inserted in the body orifice. Furthermore, the polymer of a glycol can include an anesthetic for deadening the nerves around the body orifice.
    Type: Grant
    Filed: December 10, 1979
    Date of Patent: July 14, 1981
    Assignee: Stanley Drug Products, Inc.
    Inventor: Akira Fujii
  • Method of treating bacterial infections
    Patent number: 4191779
    Abstract: A variety of substances are known which induce or alter host resistance to coccic and bacillic infections. It is also known that treatment is complicated by the ability of such organisms to develop resistance to antimicrobials. Numerous strains are known which elaborate enzymes in response to these drugs and thus remain insensitive to them. Hence there appears to be a never-ending demand for anti-coccic and anti-bacillic factors. Certain substituted benzoic acids are shown herein to render the host immune to such strains.
    Type: Grant
    Filed: March 17, 1978
    Date of Patent: March 4, 1980
    Assignee: Stanley Drug Products, Inc.
    Inventors: Elton S. Cook, Akira Fujii
  • Method of treating bacterial infections
    Patent number: 4147802
    Abstract: A variety of substances are known which induce or alter host resistance to coccic and bacillic infections. It is also known that treatment is complicated by the ability of such organisms to develop resistance to antimicrobials. Numerous strains are known which elaborate enzymes in response to these drugs and thus remain insensitive to them. Hence there appears to be a never-ending demand for anti-coccic and anti-bacillic factors. Certain substituted para-aminobenzoic acids are shown herein to render the host immune to such strains.
    Type: Grant
    Filed: March 17, 1978
    Date of Patent: April 3, 1979
    Assignee: Stanley Drug Products, Inc.
    Inventors: Elton S. Cook, Akira Fujii
  • Methods and compositions for inducing resistance to bacterial infections
    Patent number: 3995051
    Abstract: A variety of substances are reported which alter host resistance to cocci and bacilli bacterial infections. Nevertheless, because of the extreme difficulty of total eradication, and the frequent reappearance of the same strains, even after their apparently successful elimination, there is a continuing need for drugs for the treatment of coccic infections. Certain guanidinoacylhistidines are effective in inducing resistance to infections due to cocci and bacilli.
    Type: Grant
    Filed: July 10, 1975
    Date of Patent: November 30, 1976
    Assignee: Stanley Drug Products, Inc.
    Inventors: Elton S. Cook, Akira Fujii
  • Anti-microbial factors effective against bacillic and coccic infections
    Patent number: 3943244
    Abstract: Factors effective in reducing the incidence of deleterious effects of infections due to cocci and bacilli are derived by gel filtration from animal tissues.
    Type: Grant
    Filed: October 26, 1972
    Date of Patent: March 9, 1976
    Assignee: Stanley Drug Products, Inc.
    Inventors: Elton S. Cook, Norbert J. Berberich, Jr.